Abstract:Background and Purpose. Previously, we found that insulin-like growth factor-1 (IGF-1) levels in the infarct cortex in the acute phase of distal middle cerebral artery occlusion (dMCAO) rats are increased by intravenous infusion of allogeneic mesenchymal stem/stromal cells (MSCs). CD68+ microglia and NeuN+ neurons are part, but not all, of the sources of IGF-1. The present study is aimed at exploring the respective contributions of brain endogenous Iba-1+ microglia, GFAP+ astrocytes, infiltrated neutrophils, lymphocytes and monocytes/macrophages, and peripheral circulation, to the increased IGF-1 level in the infarct cortex after MSC infusion. Materials and Methods. Ischemic brain injury was induced by dMCAO in Sprague-Dawley rats. The transplantation group received MSC infusion 1 h after dMCAO. Expression of IGF-1 in GFAP+ astrocytes, Iba-1+ microglia/macrophages, CD3+ lymphocytes, Ly6C+ monocytes/macrophages, and neutrophil elastase (NE)+ neutrophils was examined to determine the contribution of these cells to the increase of IGF-1. ELISA was performed to examine IGF-1 levels in blood plasma at days 2, 4, and 7 after ischemia onset. Results. In total, only 5-6% of Iba-1+ microglia were colabeled with IGF-1 in the infarct cortex, corpus callosum, and striatum at day 2 post-dMCAO. MSC transplantation did not lead to a higher proportion of Iba-1+ cells that coexpressed IGF-1. In the infarct cortex, all Iba-1+/IGF-1+ double-positive cells were also positive for CD68. In the infarct, corpus callosum, and striatum, the majority (50-80%) of GFAP+ cells were colabeled with ramified IGF-1 signals. The number of GFAP+/IGF-1+ cells was further increased following MSC treatment. In the infarct cortex, approximately 15% of IGF-1+ cells were double-positive for CD3. MSC treatment reduced the number of infiltrated CD3+/IGF-1+ cells by 70%. In the infarct, few Ly6C+ monocytes/macrophages or NE+ neutrophils expressed IGF-1, and MSC treatment did not induce a higher percentage of these cells that coexpressed IGF-1. The IGF-1 level in peripheral blood plasma was significantly higher in the MSC group than in the ischemia control group. Conclusion. The MSC-mediated increase in IGF-1 levels in the infarct cortex mainly derives from two sources, astrocytes in brain and blood plasma in periphery. Manipulating the IGF-1 level in the peripheral circulation may lead to a higher level of IGF-1 in brain, which could be conducive to recovery at the early stage of dMCAO.

Insulin‐like Growth Factor‐1 Secreted by Brain Microvascular Endothelial Cells Attenuates Neuron Injury Upon Ischemia

Basic Fibroblast Growth Factor Alleviates Brain Injury Following Global Ischemia Reperfusion in Rabbits

The Neuroprotective Effects of Insulin-Like Growth Factor 1 Via the Hippo/YAP Signaling Pathway Are Mediated by the PI3K/AKT Cascade Following Cerebral Ischemia/reperfusion Injury

The Neuroprotective Effects of Insulin-Like Growth Factor 1 via the Hippo/YAP Signaling Pathway is Mediated by the PI3K/AKT Pathway Following Cerebral Ischemia-Reperfusion Injury

Effects of Insulin-Like Growth Factor-1 on Nerve Function and Expression of Vascular Endothelial Growth Factor Protein and Mrna after Cerebral Ischemic Reperfusion in Rats

Intravenous Administration of Hair Follicle Mesenchymal Stem Cells and Insulin Growth Factor-1 Improves the Neurological Performances of Rats Following Focal Cerebral Ischemia

The Impact of Paracrine Signaling in Brain Microvascular Endothelial Cells on the Survival of Neurons

Neuronal Injury in Rat Model of Permanent Focal Cerebral Ischemia is Associated with Activation of Autophagic and Lysosomal Pathways.

The Expression and Significance of Insulin-like Growth Factor-1 in Rats with Focal Cerebral Ischemia-reperfusion

The Effects of IGF1 and MGF on Neural Stem Cells in Hypoxic Conditions

Insulin Growth Factor-1 Gene Transfer Enhances Neurovascular Remodeling and Improves Long-Term Stroke Outcome in Mice

Peripheral Circulation and Astrocytes Contribute to the MSC-Mediated Increase in IGF-1 Levels in the Infarct Cortex in a Dmcao Rat Model

Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen–glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model

Basic Fibroblast Growth Factor Protects Astrocytes Against Ischemia/Reperfusion Injury by Upregulating the Caveolin-1/VEGF Signaling Pathway

Brain-derived neurotrophic factor mediates macrophage migration inhibitory factor to protect neurons against oxygen-glucose deprivation

The Protective Effects of Insulin-Like Growth Factor-1 on Neurochemical Phenotypes of Dorsal Root Ganglion Neurons with BDE-209-induced Neurotoxicity in Vitro

Intranasal IGF-1 Protects Against Transient Focal Cerebral Ischemia in Rats Following Middle Cerebral Artery Occlusion (MCAO)

Insulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury

Bfgf Inhibits ER Stress Induced by Ischemic Oxidative Injury Via Activation of the PI3K/Akt and ERK1/2 Pathways

rhIGF-1 reduces the permeability of the blood-brain barrier following intracerebral hemorrhage in mice

Neuro-protective Effects of Insulin-Like Growth Factor 1 on Cultured Dorsal Root Ganglion Neurons with Neurotoxicity Induced by Glutamate